Literature DB >> 17537151

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

P Valent1, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, M Castells, W R Sperr, H C Kluin-Nelemans, N A T Hamdy, O Lortholary, J Robyn, J van Doormaal, K Sotlar, A W Hauswirth, M Arock, O Hermine, A Hellmann, M Triggiani, M Niedoszytko, L B Schwartz, A Orfao, H-P Horny, D D Metcalfe.   

Abstract

Although a classification for mastocytosis and diagnostic criteria are available, there remains a need to define standards for the application of diagnostic tests, clinical evaluations, and treatment responses. To address these demands, leading experts discussed current issues and standards in mastocytosis in a Working Conference. The present article provides the resulting outcome with consensus statements, which focus on the appropriate application of clinical and laboratory tests, patient selection for interventional therapy, and the selection of appropriate drugs. In addition, treatment response criteria for the various clinical conditions, disease-specific symptoms, and specific pathologies are provided. Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials.

Entities:  

Mesh:

Year:  2007        PMID: 17537151     DOI: 10.1111/j.1365-2362.2007.01807.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  169 in total

1.  Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.

Authors:  T Gülen; B Sander; G Nilsson; J Palmblad; K Sotlar; H-P Horny; H Hägglund
Journal:  Med Oncol       Date:  2012-06-03       Impact factor: 3.064

2.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 3.  Eosinophilic myeloproliferative disorders.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 4.  [Systemic mastocytosis--definition of an internal disease].

Authors:  Jürgen Homann; Ulrich W Kolck; Andreas Ehnes; Thomas Frieling; Martin Raithel; Gerhard J Molderings
Journal:  Med Klin (Munich)       Date:  2010-09-08

5.  The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).

Authors:  Peter Valent; Michel Arock; Cem Akin; Wolfgang R Sperr; Andreas Reiter; Karl Sotlar; Karin Hartmann; Tracy I George; Knut Brockow; Hanneke C Kluin-Nelemans; Jason Gotlib; Dean D Metcalfe; Hans-Peter Horny
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

6.  Mast cell activation syndrome: Proposed diagnostic criteria.

Authors:  Cem Akin; Peter Valent; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

Review 7.  [Anaphylaxis in childhood and adolescence].

Authors:  H Ott; S Lehmann; G Wurpts; H-F Merk; A Viardot-Helmer; E Rietschel; J M Baron
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

8.  International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.

Authors:  Jason Gotlib; Animesh Pardanani; Cem Akin; Andreas Reiter; Tracy George; Olivier Hermine; Hanneke Kluin-Nelemans; Karin Hartmann; Wolfgang R Sperr; Knut Brockow; Lawrence B Schwartz; Alberto Orfao; Daniel J Deangelo; Michel Arock; Karl Sotlar; Hans-Peter Horny; Dean D Metcalfe; Luis Escribano; Srdan Verstovsek; Ayalew Tefferi; Peter Valent
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

9.  [Benign course of diffuse cutaneous mastocytosis with massive blisters].

Authors:  A Zink; M Grosber; A Schuch; T Biedermann; K Brockow
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

Review 10.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.